In a new twist on Wednesday, a DEA judge ordered the agency to respond to allegations that it opposes President Joe Biden's ...
In 2025, cannabis faces major changes with federal reclassification, easing regulations, increasing research, and opening ...
Alexander Malyshev and Sarah Ganley of Carter Ledyard & Milburn LLP discuss what the cannabis sector can expect as 2025 ...
Advocates accuse Drug Enforcement Administration of blocking the reclassification of cannabis as a Schedule III drug under the Controlled Substances Act.
The Merit Systems Protection Board needs to examine if the US government incorrectly denied a DEA agent a promotion for more ...
After serving the public for nearly 30 years and fighting to keep drugs off the streets, former DEA agent Keith Martin ...
Shares of cannabis stocks slumped after a company set to testify in the Drug Enforcement Administration's rescheduling hearings accused the agency of obstructing the rulemaking process.
The agency is accused of improperly opposing the rescheduling proposal, conspiring with prohibitionist groups and stacking ...